Net income increased 10.3%
Net income changed +10.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +10.3% from the comparable as-filed period.
Research & development changed +15.0% from the comparable as-filed period.
Revenue changed +11.5% from the comparable as-filed period.
Selling, general & administrative changed +17.0% from the comparable as-filed period.
Stock-based compensation changed +19.6% from the comparable as-filed period.
Cash & equivalents changed -3.8% from the comparable as-filed period.
Inventory changed +8.9% from the comparable as-filed period.
Debt changed +0.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.